Daily Stock Analysis, DRIO, DarioHealth Corp, priceseries

DarioHealth Corp. Daily Stock Analysis
Stock Information
Open
0.70
Close
0.73
High
0.73
Low
0.68
Previous Close
0.72
Daily Price Gain
0.01
YTD High
0.91
YTD High Date
Jan 7, 2019
YTD Low
0.65
YTD Low Date
Feb 12, 2019
YTD Price Change
-0.03
YTD Gain
-4.45%
52 Week High
2.15
52 Week High Date
Apr 26, 2018
52 Week Low
0.65
52 Week Low Date
Feb 12, 2019
52 Week Price Change
-0.76
52 Week Gain
-51.01%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 30. 2017
3.40
Feb 15. 2017
3.76
12 Trading Days
10.55%
Link
LONG
Jun 2. 2017
2.38
Jun 5. 2017
2.58
1 Trading Days
8.25%
Link
LONG
Jul 12. 2017
2.49
Jul 25. 2017
2.71
9 Trading Days
8.86%
Link
LONG
Aug 11. 2017
2.39
Aug 14. 2017
2.55
1 Trading Days
6.53%
Link
LONG
Apr 6. 2018
1.57
Apr 19. 2018
1.70
9 Trading Days
8.27%
Link
LONG
Aug 24. 2018
1.14
Aug 27. 2018
1.26
1 Trading Days
10.53%
Link
LONG
Oct 26. 2018
1.11
Oct 29. 2018
1.21
1 Trading Days
8.56%
Link
LONG
Nov 1. 2018
1.11
Nov 2. 2018
1.18
1 Trading Days
6.06%
Link
Company Information
Stock Symbol
DRIO
Exchange
NasdaqCM
Company URL
http://www.mydario.com
Company Phone
(972)-(3)-6222929
CEO
Erez Raphael
Headquarters
-
Business Address
HALAMISH 9, CAESAREA INDUSTRIAL PARK, ISRAEL 38900
Sector
-
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001533998
About

DarioHealth Corp. engages in the research, development and sale of pharmaceutical products. It provides a monitoring device, mobile application, and data services for diabetes management. It operates under the Dario brand. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Description

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its flagship product is Dario Smart Diabetes Management Solution, a mobile, real-time, cloud-based, diabetes management solution based on a multi-feature software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. The company is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid tests of body fluids using mobile devices and cloud-based services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. The company was founded in 2011 and is headquartered in Caesarea, Israel.